Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Auriemma

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Pituitary|August 21, 2015
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegalyAnnamaria Colao, Renata S Auriemma, Rosario Pivonello
Endocrine Reviews|December 3, 2010
Resistance to somatostatin analogs in acromegalyAnnamaria Colao, Renata S Auriemma, Gaetano Lombardi, et al.
Maturitas|August 27, 2021
Hyperprolactinemia after menopause: Diagnosis and managementRenata S Auriemma, Rosa Pirchio, Rosario Pivonello, et al.
Muscles, Ligaments and Tendons Journal|December 10, 2014
Cushing, acromegaly, GH deficiency and tendonsMariano Galdiero, Renata S Auriemma, Rosario Pivonello, et al.
Frontiers in Endocrinology|October 14, 2022
Metabolic effects of prolactinRosa Pirchio, Chiara Graziadio, Annamaria Colao, et al.
Expert Opinion on Drug Safety|July 18, 2015
Adverse events associated with somatostatin analogs in acromegalyLudovica F S Grasso, Renata S Auriemma, Rosario Pivonello, et al.
Expert Review of Endocrinology & Metabolism|July 31, 2018
Somatostatin analogs, cabergoline and pegvisomant: comparing the efficacy of medical treatment for acromegalyLudovica F S Grasso, Renata S Auriemma, Rosario Pivonello, et al.
Endocrinology and Metabolism Clinics of North America|March 4, 2015
Cabergoline use for pituitary tumors and valvular disordersRenata S Auriemma, Rosario Pivonello, Lucia Ferreri, et al.
Journal of Endocrinological Investigation|March 27, 2024
Long-term pasireotide therapy in acromegaly: extensive real-life experience of a referral centerR Pirchio, R S Auriemma, A Vergura, et al.
Expert Opinion on Drug Safety|February 9, 2016
The safety of treatments for prolactinomasRenata S Auriemma, Ludovica F S Grasso, Rosario Pivonello, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Pituitary|August 21, 2015
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegalyAnnamaria Colao, Renata S Auriemma, Rosario Pivonello
Endocrine Reviews|December 3, 2010
Resistance to somatostatin analogs in acromegalyAnnamaria Colao, Renata S Auriemma, Gaetano Lombardi, et al.
Maturitas|August 27, 2021
Hyperprolactinemia after menopause: Diagnosis and managementRenata S Auriemma, Rosa Pirchio, Rosario Pivonello, et al.
Muscles, Ligaments and Tendons Journal|December 10, 2014
Cushing, acromegaly, GH deficiency and tendonsMariano Galdiero, Renata S Auriemma, Rosario Pivonello, et al.
Frontiers in Endocrinology|October 14, 2022
Metabolic effects of prolactinRosa Pirchio, Chiara Graziadio, Annamaria Colao, et al.
Expert Opinion on Drug Safety|July 18, 2015
Adverse events associated with somatostatin analogs in acromegalyLudovica F S Grasso, Renata S Auriemma, Rosario Pivonello, et al.
Expert Review of Endocrinology & Metabolism|July 31, 2018
Somatostatin analogs, cabergoline and pegvisomant: comparing the efficacy of medical treatment for acromegalyLudovica F S Grasso, Renata S Auriemma, Rosario Pivonello, et al.
Endocrinology and Metabolism Clinics of North America|March 4, 2015
Cabergoline use for pituitary tumors and valvular disordersRenata S Auriemma, Rosario Pivonello, Lucia Ferreri, et al.
Journal of Endocrinological Investigation|March 27, 2024
Long-term pasireotide therapy in acromegaly: extensive real-life experience of a referral centerR Pirchio, R S Auriemma, A Vergura, et al.
Expert Opinion on Drug Safety|February 9, 2016
The safety of treatments for prolactinomasRenata S Auriemma, Ludovica F S Grasso, Rosario Pivonello, et al.
Pageof 9